John Lorbiecki - Aclarion Chief Officer
| ACON Stock | USD 0.18 0.00 0.00% |
Insider
John Lorbiecki is Chief Officer of Aclarion
| Age | 61 |
| Address | 8181 Arista Place, Broomfield, CO, United States, 80021 |
| Phone | 833 275 2266 |
| Web | https://www.aclarion.com |
Aclarion Management Efficiency
The company has return on total asset (ROA) of (1.1533) % which means that it has lost $1.1533 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.1418) %, meaning that it created substantial loss on money invested by shareholders. Aclarion's management efficiency ratios could be used to measure how well Aclarion manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aclarion's Return On Capital Employed is very stable compared to the past year. As of the 3rd of December 2024, Return On Equity is likely to grow to 7.08, while Return On Tangible Assets are likely to drop (3.99). At this time, Aclarion's Net Tangible Assets are very stable compared to the past year. As of the 3rd of December 2024, Non Currrent Assets Other is likely to grow to about 121.5 K, while Total Assets are likely to drop about 2.3 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jenwei Wu | AptarGroup | 64 | |
| Karen May | Alcon AG | 61 | |
| Arthur Cummings | Alcon AG | 57 | |
| Juan Aragon | The Cooper Companies, | N/A | |
| Ines Poschel | Alcon AG | 50 | |
| Lynn Bleil | Alcon AG | 56 | |
| Justin Leong | ResMed Inc | 47 | |
| Kimberly MacKay | West Pharmaceutical Services | 58 | |
| Amy Wakeham | ResMed Inc | N/A | |
| Vered Keisar | ResMed Inc | N/A | |
| Amy McbrideWendell | Baxter International | 60 | |
| Warner H | The Cooper Companies, | 56 | |
| Richard Rosenzweig | AngioDynamics | 57 | |
| Laurent Attias | Alcon AG | 56 | |
| Constance Bienfait | ResMed Inc | N/A | |
| Candace Matthews | AptarGroup | 61 | |
| Heidi Tlili | AptarGroup | 49 | |
| S Attias | Alcon AG | 52 | |
| Rajkumar Narayanan | Alcon AG | 56 | |
| Mark Drury | The Cooper Companies, | 45 | |
| Sergio Duplan | Alcon AG | 52 | |
Management Performance
| Return On Equity | -7.14 | ||||
| Return On Asset | -1.15 |
Aclarion Leadership Team
Elected by the shareholders, the Aclarion's board of directors comprises two types of representatives: Aclarion inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aclarion. The board's role is to monitor Aclarion's management team and ensure that shareholders' interests are well served. Aclarion's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aclarion's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeffrey MD, Executive Chairman | ||
| Ryan Bond, Chief Officer | ||
| Brent Ness, President CEO | ||
| John Lorbiecki, Chief Officer |
Aclarion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aclarion a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.14 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (103.51) % | ||||
| Current Valuation | 1.58 M | ||||
| Shares Outstanding | 10.99 M | ||||
| Shares Owned By Insiders | 9.76 % | ||||
| Shares Owned By Institutions | 3.57 % | ||||
| Number Of Shares Shorted | 380.86 K | ||||
| Price To Book | 0.79 X | ||||
| Price To Sales | 36.68 X |
Pair Trading with Aclarion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aclarion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will appreciate offsetting losses from the drop in the long position's value.Moving against Aclarion Stock
The ability to find closely correlated positions to Aclarion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aclarion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aclarion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aclarion to buy it.
The correlation of Aclarion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aclarion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aclarion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aclarion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclarion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aclarion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.40) | Revenue Per Share 0.015 | Quarterly Revenue Growth (0.36) | Return On Assets (1.15) | Return On Equity (7.14) |
The market value of Aclarion is measured differently than its book value, which is the value of Aclarion that is recorded on the company's balance sheet. Investors also form their own opinion of Aclarion's value that differs from its market value or its book value, called intrinsic value, which is Aclarion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aclarion's market value can be influenced by many factors that don't directly affect Aclarion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aclarion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aclarion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aclarion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.